Transactions
Jan. 15, 2002
Transaction Demands Juggling, Quarterbacking
Kohl co-led drug company COR Therapeutics Inc. of San Francisco in its $2 billion acquisition by Millennium Pharmaceuticals of Cambridge, Mass. Kohl talks about the deal, including his switch from tax adviser to merger and acquisition specialist.
Firm: Palo Alto's Cooley Godward
Practice Area: Tax law, corporate law and mergers and acquisitions
Age: 45
Kohl co-led drug company COR Therapeutics Inc. of San Francisco in its $2 billion acquisition by Millennium Pharmaceuticals of Cambridge, Mass. Kohl talks about the deal, includ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In